Acetophenazine

Acetophenazine

SCHEMBL123791

CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2.O=C([O-])/C=C\C(=O)[O-].O=C([O-])/C=C\C(=O)[O-].[H+].[H+].[H+].[H+]

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DRD2

The experimentally established mechanism targets of Acetophenazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 known ✓ P14416 8/20 0.85
HRH1 P35367 10/20 0.85
HTR1A P08908 7/20 0.85
SLC6A2 P23975 7/20 0.85
SLC6A4 P31645 7/20 0.85
ADRA1A P35348 7/20 0.85
DRD3 P35462 7/20 0.85
SLC6A3 Q01959 7/20 0.85
KCNH2 Q12809 7/20 0.85
ADRA2B P18089 6/20 0.85
ADRA2C P18825 6/20 0.85
HTR2A P28223 6/20 0.85
ADRA2A P08913 6/20 0.85
HTR2B P41595 5/20 0.85
DRD1 P21728 5/20 0.85
HRH3 Q9Y5N1 2/20 0.85
MLNR O43193 1/20 0.85
ESR1 P03372 1/20 0.85
PTGS2 P35354 1/20 0.85
CYP1A2 P05177 6/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetophenazine SCHEMBL29710923 0.92 HRH1 (1.00) HRH1DRD2HTR1ASLC6A2SLC6A4
Acetophenazine SCHEMBL94266 0.92 HRH1 (1.00) HRH1DRD2HTR1ASLC6A2SLC6A4
Acetophenazine SCHEMBL1155759 0.91 HRH1 (0.89) HRH1DRD2HTR1ASLC6A2SLC6A4
Acetophenazine SCHEMBL123792 0.91 HRH1 (0.89) HRH1DRD2HTR1ASLC6A2SLC6A4
Acetophenazine SCHEMBL123789 0.91 HRH1 (0.89) HRH1DRD2HTR1ASLC6A2SLC6A4
Acetophenazine SCHEMBL30903895 0.91 HRH1 (0.89) HRH1DRD2HTR1ASLC6A2SLC6A4
Acetophenazine SCHEMBL20339946 0.87 HRH1 (0.89) HRH1DRD2HTR1ASLC6A2SLC6A4
Acetophenazine SCHEMBL27848793 0.87 HRH1 (0.89) HRH1DRD2HTR1ASLC6A2SLC6A4
Perphenazine SCHEMBL871707 0.87 MAPT (0.81) HRH1DRD2HTR1ASLC6A2SLC6A4
SCHEMBL141601 0.85 HTR1A (0.86) HRH1DRD2HTR1ASLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2154 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230003721-A1 MITOTHERAPEUTICS FOR THE TREATMENT OF BRAIN DISORDERS THE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. 2023-01-05 US claimed
US-20200095627-A1 MOLECULAR SENSORS AND USES THEREOF NEW YORK UNIVERSITY 2020-03-26 US claimed
US-20190145960-A1 COMPOSITIONS, SYSTEMS AND METHODS FOR GENE EXPRESSION NOISE DRUG SCREENING AND USES THEREOF THE J. DAVID GLADSTONE INSTITUTES, A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J. DAVID GLADSTONE 2019-05-16 US claimed
EP-3470536-A1 COMPOSITIONS, SYSTEMS AND METHODS FOR GENE EXPRESSION NOISE DRUG SCREENING AND USES THEREOF The J. David Gladstone Institutes (US) 2019-04-17 EP claimed
US-10184933-B2 Compositions, systems and methods for gene expression noise drug screening and uses thereof The J. David Gladstone Industries (US) 2019-01-22 US claimed
US-20170112829-A1 USE OF COMPOUNDS BINDING TO THE SIGMA RECEPTOR LIGANDS FOR THE TREATMENT OF NEUROPATHIC PAIN DEVELOPING AS A CONSEQUENCE OF CHEMOTHERAPY LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2017-04-27 US claimed
US-20160245796-A1 COMPOSITIONS, SYSTEMS AND METHODS FOR GENE EXPRESSION NOISE DRUG SCREENING AND USES THEREOF THE J. DAVID GLADSTONE INSTITUTES (US) 2016-08-25 US claimed
EP-3052662-A1 COMPOSITIONS, SYSTEMS AND METHODS FOR GENE EXPRESSION NOISE DRUG SCREENING AND USES THEREOF The J. David Gladstone Institutes (US) 2016-08-10 EP claimed
EP-1349835-B1 (+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE, COMPOSITIONS AND USES THEREOF EUTHYMICS BIOSCIENCE INC (US) 2016-03-30 EP claimed
US-20150148256-A1 BIOLUMINESCENCE IMAGING-BASED SCREENING ASSAY AND INHIBITORS OF ABCG2 THE JOHNS HOPKINS UNIVERSITY (US) 2015-05-28 US claimed
WO-2002066427-A2 (+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE, COMPOSITIONS AND USES THEREOF DOV PHARMACEUTICAL, INC. (US) 2002-08-29 WO claimed
US-6372919-B1 SUBSTANTIALLY FREE OF CORRESPONDING (-)-ENANTIOMER DOV PHARMACEUTICAL, INC. 2002-04-16 US claimed
US-6197764-B1 COMPLEX WITH FATTY ACID; THERAPY FOR PSYCHOLOGICAL DISORDERS PROTARGA, INC. 2001-03-06 US claimed
EP-1044023-A1 A COVALENT CONJUGATE OF CLOZAPINE WITH A FATTY ACID AND ITS USE FOR TREATING SCHIZOPHRENIA Protarga Inc. (US) 2000-10-18 EP claimed
US-5955459-A Fatty acid-antipsychotic compositions and uses thereof NEUROMEDICA, INC. (US) 1999-09-21 US claimed
WO-1999026661-A1 A COVALENT CONJUGATE OF CLOZAPINE WITH A FATTY ACID AND ITS USE FOR TREATING SCHIZOPHRENIA PROTARGA INC. (US) 1999-06-03 WO claimed
EP-0580776-A1 USE OF SIGMA RECEPTOR ANTAGONISTS TO ENHANCE THE EFFECTS OF ANTIPSYCHOTIC DRUGS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-02-02 EP claimed
WO-1992018127-A1 USE OF SIGMA RECEPTOR ANTAGONISTS TO ENHANCE THE EFFECTS OF ANTIPSYCHOTIC DRUGS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-10-29 WO claimed
EP-0180364-B1 PHARMACEUTICAL COMPOSITIONS CONTAINING PHENOTHIAZINES RECKITT AND COLMAN PRODUCTS LIMITED (GB) 1990-03-07 EP claimed
EP-0180364-A2 Pharmaceutical compositions containing phenothiazines RECKITT AND COLMAN PRODUCTS LIMITED (GB) 1986-05-07 EP claimed